64 In the index

Pramiracetam PRAM

A stronger brain-supplement compound studied in small human trials for memory problems after a head injury. Those limited studies suggested some benefit, but modern, large-scale research is lacking and it isn't approved for any use.

Also known as Pramistar, Pramiracetamum, 4449F8I3LE, RefChem:175719, N06BX16, Pramiracetam [INN], Pramiracetam hydrate, Pramiracetam (INN)

Effects Focus

Routes Oral

Legal status Unscheduled

WADA Not listed

3D Molecular Structure of C₁₄H₂₇N₃O₂

Drag to rotate · scroll to zoom

Chemistry

Formula: C14H27N3O2
Molar mass: 269.38
CAS: 68497-62-1
PubChem CID: 51712
IUPAC name: N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
InChIKey: ZULJGOSFKWFVRX-UHFFFAOYSA-N

Reported dosing

Clinical data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 400 mg

Reported range 400-1200 mg/day

Route Oral

Frequency 2-3 times daily

Duration Ongoing (supplement use)

Studied clinically in Europe for cognitive impairment but not FDA-approved; sold as an unregulated nootropic supplement in the US.

Where this comes from European clinical trials; supplement-industry dosing

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.